Customer Support: 800-526-4902
 
Home > Foley Hoag LLP > Offices > Office Profile


Foley Hoag LLP

  - Office Profile
 




Foley Hoag LLP 
Boston, Massachusetts Office
View all offices

Seaport World Trade Center West, 155 Seaport Boulevard
Boston, Massachusetts  02210-2600
(Suffolk Co.)

Telephone: 617-832-1000
Telecopier: 617-832-7000
http://www.foleyhoag.com



Profile Visibility
#14 in weekly profile views out of 1,925 law firms in Boston, Massachusetts
#904 in weekly profile views out of 263,288 total law firms Overall

Lex Mundi

General PracticeIntellectual Property Law
Labor and Employment Law
 
               Learn More

 



 

Statement of Practice Summary:
General Practice. Securities, Litigation, Tax, Environmental, Labor & Employment, Banking, High Technology, Biotechnology, Real Estate, Transportation, Energy/Utilities, International, Bankruptcy, Copyright, Trademark, Patent and Intellectual Property Law, Health Care, Government Relations, Education, Estate Planning and Probate, White Collar Crime, Business, Corporate Finance, Land Use, Immigration, Trials and Appeals in all Courts.


Documents by Lawyers at this office
Subscribe to this feed

Charitable Giving Initiative Under Consideration by Massachusetts Legislature
Kevin C. Conroy,Noah J. Kaufman,Sharon C. Lincoln, February 14, 2012
A proposed law under consideration in Massachusetts may make it easier for Massachusetts residents to financially support their favorite charity. For charitable organizations that have seen declining levels of donations over the past few years, the proposed law might create a new avenue through...

FDA Releases Long-Awaited Draft Guidances on Biosimilar Product Development
Barbara A. Fiacco,James M. Flaherty,Paul T. Kim,Donald R. Ware, February 13, 2012
Today, the U.S. Food and Drug Administration (FDA) released three draft guidance documents designed to assist industry in developing biosimilars. Biosimilar products are biological products shown to be highly similar (biosimilar) to biological products previously approved by FDA (known as...

FDA’s Draft Guidance on Scientific Considerations in Demonstrating Biosimilarity
Barbara A. Fiacco,James M. Flaherty,Paul T. Kim,Donald R. Ware, February 13, 2012
Yesterday, the U.S. Food and Drug Administration released three draft guidance documents designed to assist industry in developing biosimilars and implementing the new abbreviated biologics approval pathway under section 351(k) of the Biologics Price Competition and Innovation Act of 2009 (BPCI...





Return to the Foley Hoag LLP Firm Overview


 

Complete a Client Review


Have you recently worked with this firm? Share your experience as a Client of this firm and complete a Client Review to help others make an informed choice when hiring legal counsel.
 
 

Purchase Report

Buy an atVantage Firm Profile for insight into a law firm's litigation, bankruptcy, corporate transaction and patent prosecution experience.
 
 

Compare this Firm

Compare this firm to other firms in your Favorites.
 

Add firm to Favorites

As a registered user of martindale.com Connected, you can add firms to your list of Favorites. You can securely add comments and compare the firms in your Favorites.